Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by robertshawon Apr 17, 2022 11:22am
177 Views
Post# 34608371

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Rutherrin

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Rutherrin
Infinity wrote: Fredgoodwinson,  There is no question, that we have a very viable product with huge potential to cure or mitigate a major cancer.  The Management by choice fail to communicate this and witholds major developments, blatantly put out confusing data that can be interpreted in many ways.   If they continue to take the share holders for granted, they will pay a heavy price in the event of a take over bid.  If that materialises,  I will be the first one to vote for a change in Management!!.  I truly believe that I am not the only share holder who would vote in favour of a major pharma company, in the event of a take over bid.


Completely agree. More than 8 years much promise yet less carry out, the only trustworthy side is science... That's the only reason most people are still here
<< Previous
Bullboard Posts
Next >>